Edition:
United Kingdom

PTC Therapeutics Inc (PTCT.OQ)

PTCT.OQ on NASDAQ Stock Exchange Global Select Market

39.49USD
8:00pm GMT
Change (% chg)

$1.72 (+4.55%)
Prev Close
$37.77
Open
$37.35
Day's High
$39.63
Day's Low
$37.22
Volume
258,835
Avg. Vol
304,134
52-wk High
$52.95
52-wk Low
$24.73

Chart for

About

PTC Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid (RNA) biology. Its product pipeline includes Ataluren (Translarna), PTC596 and RG7916. Its product candidate, ataluren, is an orally administered... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $812.47
Shares Outstanding(Mil.): 41.39
Dividend: --
Yield (%): --

Financials

  PTCT.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -3.10 -- --
ROI: -37.56 8.89 13.82
ROE: -64.70 10.00 15.25

Earnings vs. Estimates